Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

A7-183: Effective topical therapy of recurrent herpes labialis and genitalis

June 7, 1996

Xoma granted U.S. patent for use of BPI

June 7, 1996

Kyowoa Hakko's RP-1551-2: a novel antimicrobial agent

June 7, 1996

Glaxo Wellcome and Otsuka sign grepafloxacin licensing agreement

June 7, 1996

Antiherpes prodrug shows greater activity than aciclovir

May 31, 1996

FDA approves piperacillin sodium/tazobactam sodium for new indication

May 31, 1996

Bayer announces formulation of antibacterial agents

May 31, 1996

Clinical data from Lidakol phase III studies

May 24, 1996

Preliminary phase II results for HNK20

May 24, 1996

RSV inhibitors presented by Wyeth-Ayerst

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...